Presbyopia on the Table: What Works, What’s Next—Live from APAO 2025
From game-changing IOLs to laser scleral therapy, this APAO 2025 session suggests presbyopia correction is getting personal. The first day…
Opus Genetics Announces FDA Fast Track Nod for Night Driving Impairment Drug, Clinical Updates
Opus gave positive updates on its late-stage candidate for presbyopia, pharmacologically induced mydriasis and dim light disturbances in keratorefractive patients….
popular posts
latest posts